A new technology called “Sticky-flares” developed by nanomedicine scientists offers the first real-time method to track and observe the dynamics of RNA distribution as it is transported inside living cells.
Elizabeth McNally, MD, PhD, director of the Center for Genetic Medicine, testified before the U.S. House of Representatives Subcommittee on Research and Technology about the science and ethics of genetically engineered human DNA.
A new study reveals the biochemical mechanisms underlying kidney hypertrophy. The findings were published in a paper coauthored by Eric G. Neilson, MD, vice president for Medical Affairs and Lewis Landsberg Dean.
David Gius, MD, PhD, professor in Radiation Oncology and Pharmacology, collaborated with University of Chicago scientists on a study identifying a natural compound that activates the protein SIRT3, a potential target for breast cancer, cardiac conditions and other diseases.
Chad Mirkin, PhD, and colleagues show that spherical nucleic acids can be used to regulate immune responses in a new study that could shift the way scientists think about developing therapeutic agents for many diseases.
Northwestern Medicine scientists have developed a method to systematically explore diverse natural resources, allowing them to quickly identify thousands of compounds from bacteria that have potential to become new pharmaceuticals.
In several recent publications, Ali Shilatifard, PhD, chair of Biochemistry and Molecular Genetics, examined how different aspects of transcriptional regulation are involved in cancer development.
Marilyn Cornelis, PhD, assistant professor in Preventive Medicine-Nutrition, draws on systems epidemiology approaches in her research to understand the potential health consequences of coffee consumption.
Jonathan Leis, PhD, professor in Microbiology-Immunology, received a grant to support his research on small molecule inhibitors that block the replication of enveloped viruses such as herpes and HIV.
Ali Shilatifard, PhD, started assisting in his grandfather’s lab in Tehran at age 5. Years later, Northwestern lands this acclaimed scientist to lead the new Department of Biochemistry and Molecular Genetics and halt cancer.